FRANK STOLBA
@Ingalls & Snyder Llc
Latest period2024 - Q3ReportedManaged Assets$2.563BTotal holdings440
Assets growth rate10.18%Assets growth rate (2-Q avg)6.44%Continuous growth in asset value4 quarters
Portfolio positions
This chart displays the top 10 holdings in Ingalls & Snyder Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 440 positions.
Assets under management
The assets under management (AUM) of Ingalls & Snyder Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.563B in assets, with a quarterly growth rate of 10.18% and a 2-quarter average growth rate of 6.44%. The portfolio is managed by FRANK STOLBA, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
ABTAbbott Labs
| 1.1% | $28.118M 246,630 shares@ $114.01 avg price | Decreased -0.11% |
MRKMerck & Co Inc
| 1.08% | $27.66M 243,574 shares@ $113.56 avg price | Decreased -1.25% |
ABBVAbbvie Inc
| 1.08% | $27.576M 139,640 shares@ $197.48 avg price | Decreased -6.57% |
HXLHexcel Corp New
| 0.97% | $24.668M 398,970 shares@ $61.83 avg price | Decreased -0.42% |
RRCRange Res Corp
| 0.96% | $24.457M 795,075 shares@ $30.77 avg price | Decreased -0.27% |
ULUnilever Plc
| 0.93% | $23.645M 363,986 shares@ $64.97 avg price | Decreased -0.82% |
CBChubb Limited
| 0.82% | $20.784M 72,068 shares@ $288.4 avg price | Decreased -0.96% |
GSGoldman Sachs Group Inc
| 0.78% | $19.908M 40,210 shares@ $495.11 avg price | Decreased -12.32% |
PFEPfizer Inc
| 0.77% | $19.674M↑ Call 679,839 shares@ $28.94 avg price | Decreased -0.05% |
CCitigroup Inc
| 0.71% | $18.147M↑ Call 289,889 shares@ $62.6 avg price | Decreased -7.42% |